Skip to content
SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%SENSEX81,250.32+0.42%NIFTY 5024,680.10+0.35%BANK NIFTY52,340.55-0.21%FIN NIFTY23,110.75+0.18%DOW JONES39,750.20-0.12%NASDAQ17,890.40+0.55%S&P 5005,460.30+0.29%GOLD71,500.00+0.65%SILVER84,200.00+1.10%USD/INR83.42-0.05%BITCOIN5,820,000.00+2.35%

No Fancy Headshot, No 'Visionary Leader': Apple CEO's LinkedIn Profile Sparks Debate

No Fancy Headshot, No ‘Visionary Leader’: Apple CEO’s LinkedIn Profile Sparks Debate  NDTVApple’s 2,275% gain under Tim Cook is a tough act for John Ternus to follow  ET BrandEquityHow John Ternus’s era will shape Apple  The HinduApple’s Ternus Touts Product Pipeline, ‘Phenomenal’ iPhone Launch in Memo  Bloomberg.comTim Cook Morning…

Tata Motors launches tender offer for Iveco shares after securing all regulatory clearances

Tata Motors launches tender offer for Iveco shares after securing all regulatory clearances  Moneycontrol.comTata Motors launches tender offer for common shares of Iveco Group  The HinduTata Motors’ Iveco acquisition offer gets Italian regulator nod, acceptance period opens Sept 7  ET AutoTata Motors Iveco takeover: Shareholder tender opens September…

Rs 10,000-crore question mark over Ratan Tata estate

Rs 10,000-crore question mark over Ratan Tata estate  The Economic TimesTata Trusts gets relief in probe, clears way for new Tata Sons chairman selection  Telegraph IndiaCan Ratan Tata’s inherited shares go to his charities?  The Times of India“Unbecoming of trustee”: Tata Trusts comment, says Vijay Singh; Tata Trusts…

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal

Novartis Says Closely Watched Cholesterol Study Failed to Meet Goal  WSJNovartis, Ionis’ experimental heart drug misses key goal in closely watched trial  ReutersThe Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists  The New York TimesRoyalty Pharma expects modest return despite pelacarsen trial failure  in.investing.comNovartis Lp(a) drug fails to lower…

OpenAI’s rogue agents keep escaping, with no formal process to investigate them

OpenAI’s rogue agents keep escaping, with no formal process to investigate them  TechCrunchThousands of OpenAI AI agents took over German website, researchers say  The HinduWhy the Hugging Face Hack Should Make You Worry More About A.I.  The New York TimesEXCLUSIVE: OpenAI agents hijacked German website in previously undisclosed…

From phones to jets? Dixon eyes aerospace, defence and auto for next big push

From phones to jets? Dixon eyes aerospace, defence and auto for next big push  Moneycontrol.comDixon Technologies: New Foray into Aerospace, Defence, Medical  Rediff MoneyWizDixon Technologies files FY26 BRSR report, cuts plants to seven  scanx.tradeGemtek and Dixon deepen strategic collaboration through JV in India to serve AI and data…